share_log

遠大醫藥:自願性公告: 本集團全球創新眼科藥物GPN00884 在中國獲批開展I 期臨床研究

GRANDPHARMA: VOLUNTARY ANNOUNCEMENT: THE GROUPS GLOBAL INNOVATIVE OPHTHALMIC DRUG GPN00884 WAS APPROVED TO CONDUCT PHASE I CLINICAL STUDY IN CHINA

香港交易所 ·  Mar 7 04:36
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more